Physician profile
Dagnachew Assefa
NPI 1831170794
$1,735.47
in general payments reported to CMS, 2019-2025
20 companies · $25.71 in 2025
The $25.71 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $369 · 2021: $477 · 2022: $166 · 2023: $101 · 2024: $124 · 2025: $25.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $266.82 | 2019-2025 | Dupixent |
| Genzyme Corporation | $212.47 | 2019-2023 | |
| Glaxosmithkline, LLC. | $159.06 | 2019-2023 | Nucala |
| Astrazeneca Pharmaceuticals LP | $153.82 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $135.02 | 2021 | |
| Chiesi USA, INC. | $128.47 | 2019 | |
| Abbvie INC. | $125.92 | 2019-2022 | |
| Mylan Specialty L.P. | $124.31 | 2024 | Tobi Podhaler |
| Kaleo, INC. | $108.29 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.40 | 2020 | |
| Genentech USA, INC. | $49.75 | 2019-2021 | |
| Philips North America LLC | $33.79 | 2020 | |
| Alcresta Therapeutics, INC. | $28.30 | 2022 | |
| Allergan, INC. | $28.08 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $26.77 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $25.05 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $21.43 | 2019 | |
| Ucb, INC. | $19.05 | 2021 | |
| Medical Graphics Corporation | $15.11 | 2019 | |
| Vapotherm INC | $14.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dagnachew Assefa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.